RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Collegium Pharmaceutical

Collegium Pharmaceutical Market capitalization 2024

Collegium Pharmaceutical Market capitalization

1.35 B USD

Collegium Pharmaceutical Dividend yield

Ticker

COLL

ISIN

US19459J1043

WKN

A14SUV

In 2024, Collegium Pharmaceutical's market cap stood at 1.35 B USD, a 38.71% increase from the 972.2 M USD market cap in the previous year.

The Collegium Pharmaceutical Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2028e489.566,63257.57
2027e404.8680,56117.11
2026e581.1456,13267.05
2025e609.6853,50237.7
2024e595.354,79213.9
2023566.7757,5548.16
2022463.946,20-25
2021276.954,3971.5
202031058,0026.8
2019296.734,72-22.7
2018280.440,91-39.1
201728.590,88-74.9
20161.788,24-94.2
2015---20
2014---17.9
2013---16.2

Collegium Pharmaceutical Aktienanalyse

What does Collegium Pharmaceutical do?

Collegium Pharmaceutical Inc is a biopharmaceutical company specializing in the development and marketing of innovative drugs for the treatment of pain and inflammation conditions. The company was founded in 2002 by Michael Heffernan and Mark Trudeau and is headquartered in Stoughton, Massachusetts. Collegium Pharmaceutical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Collegium Pharmaceutical's Market Capitalization

Collegium Pharmaceutical's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Collegium Pharmaceutical's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Collegium Pharmaceutical's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Collegium Pharmaceutical’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Collegium Pharmaceutical Stock

What is the current Collegium Pharmaceutical market capitalization?

The current market capitalization of Collegium Pharmaceutical is 1.35 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Collegium Pharmaceutical.

How has the market capitalization of Collegium Pharmaceutical developed in recent years?

The market capitalization of Collegium Pharmaceutical has increased/decreased by 38.71% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Collegium Pharmaceutical?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Collegium Pharmaceutical?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Collegium Pharmaceutical have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Collegium Pharmaceutical pay?

Over the past 12 months, Collegium Pharmaceutical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Collegium Pharmaceutical is expected to pay a dividend of 0 USD.

What is the dividend yield of Collegium Pharmaceutical?

The current dividend yield of Collegium Pharmaceutical is .

When does Collegium Pharmaceutical pay dividends?

Collegium Pharmaceutical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Collegium Pharmaceutical?

Collegium Pharmaceutical paid dividends every year for the past 0 years.

What is the dividend of Collegium Pharmaceutical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Collegium Pharmaceutical located?

Collegium Pharmaceutical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Collegium Pharmaceutical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Collegium Pharmaceutical from 6/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/4/2024.

When did Collegium Pharmaceutical pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Collegium Pharmaceutical in the year 2023?

In the year 2023, Collegium Pharmaceutical distributed 0 USD as dividends.

In which currency does Collegium Pharmaceutical pay out the dividend?

The dividends of Collegium Pharmaceutical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Collegium Pharmaceutical stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Collegium Pharmaceutical

Our stock analysis for Collegium Pharmaceutical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Collegium Pharmaceutical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.